HealThink participates in ISPOR Europe 2023
HealThink will participate in the conference and present posters regarding some of our projects.
We are very glad that one of our posters “Early Health Economic Modelling to Support the Development of Lifechamps Digital Platform for Older Cancer Survivors” will be presented in the topic Medical Technologies, which are a main sector of our interest, knowledge and activities. LifeChamps is an EU Horizon 2020 project that aims to create a digital platform to enable monitoring of health-related quality of life and frailty in cancer survivors over the age of 65. The objective of this analysis is to assess the potential value of this technology before clinical testing and to identify information gaps and uncertainties, optimizing further research and development. More details here.
We will also present:
As healthcare policy is evolving rapidly to address issues around use of real-world evidence (RWE), cross-border collaboration, affordability, and equity, ISPOR Europe 2023 will address these issues and more, with a sharp focus on the role of health economics and outcomes research (HEOR) science in shaping policy.
HealThink has focused its scientific interest in RWE and provides integrated services to pharma industry, medical associations etc. We will be there to attend the discussion and dissemination of the latest trends!
We are very glad that one of our posters “Early Health Economic Modelling to Support the Development of Lifechamps Digital Platform for Older Cancer Survivors” will be presented in the topic Medical Technologies, which are a main sector of our interest, knowledge and activities. LifeChamps is an EU Horizon 2020 project that aims to create a digital platform to enable monitoring of health-related quality of life and frailty in cancer survivors over the age of 65. The objective of this analysis is to assess the potential value of this technology before clinical testing and to identify information gaps and uncertainties, optimizing further research and development. More details here.
We will also present:
- The Economic Impact of Third Line Chronic Phase Chronic Myeloid Leukemia Treatment in Greece From a National Payer Perspective (Economic Evaluation/ Oncology, Rare & Orphan Diseases). More details here.
- Cost-Effectiveness Analysis of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Greece (Economic Evaluation/ Oncology). More details here.
As healthcare policy is evolving rapidly to address issues around use of real-world evidence (RWE), cross-border collaboration, affordability, and equity, ISPOR Europe 2023 will address these issues and more, with a sharp focus on the role of health economics and outcomes research (HEOR) science in shaping policy.
HealThink has focused its scientific interest in RWE and provides integrated services to pharma industry, medical associations etc. We will be there to attend the discussion and dissemination of the latest trends!